1. Collaborative and Proactive Solutions compared with usual care to treat irritability in children and adolescents: a pilot randomized controlled trial.
- Author
-
Mulraney, Melissa, Sciberras, Emma, Payne, Jonathan M, De Luca, Cinzia, Mills, John, Tennant, Michelle, and Coghill, David
- Subjects
- *
ANGER management , *EXECUTIVE function , *PILOT projects , *PSYCHOLOGY of parents , *MENTAL health , *TREATMENT effectiveness , *RANDOMIZED controlled trials , *COMPARATIVE studies , *INTERPROFESSIONAL relations , *QUALITY of life , *DESCRIPTIVE statistics , *STATISTICAL sampling , *FAMILY relations , *ANGER , *PSYCHOTHERAPY , *LONGITUDINAL method , *EVALUATION , *CHILDREN , *ADOLESCENCE - Abstract
This pilot randomised controlled trial evaluated the acceptability and feasibility of a psychological intervention to manage severe irritability in children and adolescents. Children with severe irritability (9–14 years; 42% male) were randomised to receive six sessions of Collaborative & Proactive Solutions (CPS) or usual clinical care. The primary outcome was acceptability and feasibility of the intervention (participant enrollment, drop-out, intervention session attendance). Key secondary outcomes assessed 4-month post-randomisation included child irritability, quality of life, executive functioning, parent mental health and family functioning. Twelve children enrolled in the study (52% uptake). All participants in the CPS group attended ≥2 intervention sessions, and one participant in the usual care group was lost to follow-up. Compared to usual care, the CPS group had improvements in child irritability (Effect Size (ES): −0.4), quality of life (ES: 0.4), executive functioning (ES: −0.4), and family functioning (ES: −0.7). It is acceptable and feasible to deliver CPS to severely irritable children and adolescents. Preliminary evidence suggests this non-pharmacological intervention improves important areas of functioning for severely irritable children. The trial was prospectively registered on 11 October 2017 with the Australian New Zealand Clinical Trials Registry (: ACTRN12617001445369). [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF